Use Of MicroRNA-205 (miR-205) For The Treatment And Diagnosis Of Parkinson Disease
US Application 61/430,626
Filed on 2011-01-07
Filed on 2011-01-07
Compositions and Methods for Treating Neoplasia
US Application 61/416,619
Filed on 2010-11-23
Filed on 2010-11-23
Posiphen And Analogues Suppress Production Of Alpha-synculein Protein
US Application 61/164,729
Filed on 2009-03-30
Filed on 2009-03-30
REGULATORY B CELLS (tBREGS) AND THEIR USE
US Application 61/302,074
Filed on 2010-02-05
Filed on 2010-02-05
THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS
US Application 61/312,642
Filed on 2010-03-10
Filed on 2010-03-10
METHODS FOR ENHANCING GENOME STABILITY AND TELOMERE ELONGATION IN EMBRYONIC STEM CELLS
US Application 61/275,983
Filed on 2009-09-04
Filed on 2009-09-04
Engineering Rhythmic And Responsive Biological Pacemakers Based on The Enhancement Of Cell Intracellular Signaling Targeting Both Ca Cycling And Sarcolemma
US Application 61/180,491
Filed on 2009-05-22
Filed on 2009-05-22
Sperm-derived SPANX-B Is A Clinically Relevant Tumor Antigen That Is Expressed In human Tumors And Readily Recognized By Human CD4+ And CD8+ T Cells
US Application 61/156,435
Filed on 2009-02-27
Filed on 2009-02-27
Design And Generation Of Membrane-targeting And Epitope-tagging Module For Subcloning And Expression Ofmammalian Membrane Proteins
US Application 61/142,531
Filed on 2009-01-05
Filed on 2009-01-05
Serum Carboxymethyl-lysine And Circulating Receptor For Advanced Glycation End Products (RAGE) Es Clinical Biomarkers For Adverse Aging-related Outcomes
US Application 61/133,510
Filed on 2008-06-30
Filed on 2008-06-30